Wave Life Sciences Ltd.
WVE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,710,492 | $535,791 | $551,991 | $162,732 |
| - Cash | $302,078 | $200,351 | $88,497 | $150,564 |
| + Debt | $25,404 | $32,118 | $37,614 | $29,916 |
| Enterprise Value | $1,433,818 | $367,558 | $501,108 | $42,084 |
| Revenue | $108,302 | $113,305 | $3,649 | $40,964 |
| % Growth | -4.4% | 3,005.1% | -91.1% | – |
| Gross Profit | $108,302 | $113,305 | $3,649 | $40,964 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$101,740 | -$58,790 | -$152,606 | -$117,181 |
| % Margin | -93.9% | -51.9% | -4,182.1% | -286.1% |
| Net Income | -$97,008 | -$57,513 | -$161,823 | -$122,245 |
| % Margin | -89.6% | -50.8% | -4,434.7% | -298.4% |
| EPS Diluted | -0.7 | -0.54 | -2.05 | -2.36 |
| % Growth | -29.6% | 73.7% | 13.1% | – |
| Operating Cash Flow | -$151,026 | -$19,431 | -$127,781 | -$88,993 |
| Capital Expenditures | -$938 | -$1,115 | -$1,361 | -$560 |
| Free Cash Flow | -$151,964 | -$20,546 | -$129,142 | -$89,553 |